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transcriptional factor SOX4 expression in
human gastric carcinomaKai-Yuan Lin a,b, Yih-Huei Uen a,c,da Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan
b Department of Biotechnology, Cha Nan University of Pharmacy and Science, Tainan, Taiwan
c Superintendent’s Office, Chi Mei Hospital Chiali, Tainan, Taiwan
d Institute of Biomedical Engineering, Southern Taiwan University of Science and Technology,
Tainan, TaiwanBackground: Gastric carcinoma (GC) is one of the most common malignancies in the world, yet little is known about the
molecular process of its development and progression. In this study, we investigated the involvement of transcription factor
SOX4 in tumor progression, and in the prognosis of human GC.
Materials and Methods: Expression levels of nuclear SOX4 were analyzed in 108 gastric tissues from patients with GC by
immunohistochemistry. A paired t test was used to analyze the differences in SOX4 expression between tumor and non-
tumor tissues in the same patient. A two-tailed c2 test was performed to determine the significance of the difference
between SOX4 expression and clinicopathologic parameters. All time-to-event endpoints according to various clinico-
pathologic parameters were plotted by the Kaplan-Meier method and the significance was then determined by a uni-variate
log-rank test. Cox proportional hazards model was used for multi-variate analysis to determine the independence of
prognostic impact of SOX4 expression.
Results: Overexpression of SOX4 was associated with depth of invasion (P< 0.0001), nodal status (P Z 0.0472), distant
metastasis (PZ 0.0341), stage (PZ 0.0025), vascular invasion (PZ 0.0036), and correlated with poor disease-free survival
(P Z 0.0008). In univariate Cox regression analysis, overexpression of SOX4 was proven to be a prognostic marker for GC
(P Z 0.001).
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